Clinical role and mechanisms of action of analgesic nitrous oxide

International Journal of Neuroscience

Volumn 93, Issue 1-2, 1998, Pages 55-62

  Gillman, Mark A ^a   Lichtigfeld, Frederick J ^a  

^a South African Brain Research Institute   (South Africa)

Author keywords

Analgesic nitrous oxide; Nitric oxide addiction; Opioid

Indexed keywords

EID: 0032007247     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459808986412     Document Type: Article

References (51)

1. Alexander, J. I. & Hill, R. G. (1987). Postoperative pain control. pp. 124-125 & p. 130 (Blackwell, Oxford).
2. Bergman, J. (1994). "Opioid modification of behavioural effects of cocaine in monkeys," Neuropsychopharmacology, 10 (supplement 1), 667S-
3. Carey, C , Clark, A. & Saner, A. (1991) "Analgesic nitrous oxide for addictive withdrawal states in general practice," South African Medical Journal, 79, 516.
4. Daynes, G. (1989). "The initial management of alcoholism using oxygen and nitrous oxide: a transcultural study," International Journal of Neuroscience, 49, 83-86.
5. Di Chiara, G. & Imperato, A. (1988). "Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats," Journal of Pharmacology and Experimental Therapeutics, 244, 1067-1080.
6. Dorris, R. L. & Truong V. (1993). "Locomotor effects of nitrous oxide in mice: requirement of newlysynthesized and main intraneural storage pools of dopamine," Journal of Pharmacy and Pharmacology, 45, 315-316.
7. Ebert, T. J. (1990). "Differential effect of nitrous oxide on baroreflex control of heart rate and peripheral sympathetic nerve activity in humans." Anesthesiology, 72, 16-22.
8. 2O, pp. 41-55, (Elsevier, New York).
9. Fujimoto, J M. & Rady, J. J. (1989). "Intracerebioventricular physostigmine- induced analgesia' enhancement by naloxone, Beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A 1-17," Journal of Pharmacology and Experimental Therapeutics, 251, 1045-1052.
10. Gillman, M. A. (1986). "Minireview: Analgesic (sub anesthetic) nitrous oxide interacts with the endogenous opioid system: A review of the evidence," Life Science, 39, 1209-1221.
11. Gillman, M. A. (1987). "Haematological changes caused by nitrous oxide. Cause for concern? Editorial," British Journal of Anaesthesia, 59, 143-146.
12. Gillman, M. A (1992). "Nitrous oxide abuse in perspective," Clinical Neuropharmacology, 15, 297-306.
13. Gillman, M. A. (1994). "Psychotropic analgesic nitrous oxide as an investigate, diagnostic and therapeutic tool," International Journal of Neuroscience, 76, 1-3.
14. Gillman, M. A. & Lichtigfeld, F. J. (1981) "Possibility of an opioid and anti-opioid system," Journal of the Royal Society of Medicine, 74, 943-944.
15. Gillman, M. A. & Lichtigfeld, F J. (1984) "The opioid and anti-opioid system in addiction," South African Medical Journal, 66, 592.
16. Gillman, M. A. & Lichtigfeld, F. J. (1986). "Minimal sedation required with nitrous oxide/oxygen of the alcohol withdrawal state," British Journal of Psychiatry, 148, 604-606.
17. Gillman, M. A. & Lichtigfeld, F. J. (1989). "Analgesic nitrous oxide past present future," International Journal of Neuroscience, 49, 75-81.
18. Gillman, M. A. & Lichtigfeld, F. J. (1990). "Analgesic nitrous oxide for alcohol withdrawal a critical appraisal after 10 years' use," Postgradraduate Medical Journal, 66, 543-546.
19. Gillman, M. A. & Lichtigfeld, F. J. (1991). "Placebo and analgesic nitrous oxide for the treatment of the alcohol withdrawal state," British Journal of Psychiatry, 159, 672-675.
20. Gillman, M. A. & Lichtigfeld, F. J. (1994a). "Opioid properties of psychotropic analgesic nitrous oxide (laughing gas)," Perspectives in Biology and Medicine, 38, 125-138.
21. Gillman, M. A. & Lichtigfeld, F. J. (1994b) "Pharmacology of psychotropic analgesic nitrous oxide as a multipotent opioid agonist," International Journal of Neuroscience, 76, 5-12.
22. Gillman, M. A. & Lichtigfeld, F. J. (1994c). "NO Comments," Nature, 367, 28.
23. Gillman, M. A , Matussek, N. & Lichtigfeld, F J. (1985). Effect of nitrous oxide on depressive patients and volunteers, In P. Berner (ed.). Psychiatry: the state of the art, pp. 397-404, (Plenum, New York).
24. Griffin, G. C., Campbell, V. D. & Jones, R. (1981). "Nitrous oxide-oxygen sedation for minor surgery. Experience in a pediatric setting." Journal of the American Medical Association, 245, 2411-2413.
25. Hamilton, W. K. (1991). "Con: Nitrous oxide should be used for coronary heart disease," Journal of Cardiothoracic Surgery, 44, 189-191.
26. Hughes, J. & Kosterlitz, H. W. (1977) "Opiate peptides," British Medical Bulletin, 33, 157-161.
27. Jaffe, J. H. & Martin, W. R. (1990). Opioid analgesics and antagonists. In A. Goodman-Gilman, T. W. Rall, A. S. Nies, & P. Taylor (eds). Goodman and Gilman's the pharmacological basis, of therapeutics, pp. 485-521, (Pergamon, New York).
28. Jastak, T. J. (1989). "Nitrous oxide in dental practice," International Anesthestology Clinics, 27, 92-97.
29. Koob, G. E., Markou, A. & Schulteis, G. (1994). "The mesocorticolimbic system in opioid dependence," Neuropsychopharmacology, 10 (supplement 1), 562S.
30. Langa, H. (1976). Relative analgesia in dental practice (W.B. Saunders, Philadelphia).
31. 2O, pp. 249-257, (Elsevier, New York).
32. Lecore, A. (1994). "Effective use of psychotropic analgesic nitrous oxide in modern psychotherapy." International Journal of Neuroscience, 76, 41-48.
33. Lichtigfeld, F. J. & Gillman, M. A. (1982). "The treatment of alcoholic withdrawal states with oxygen and nitrous oxide," South African Medical Journal, 61, 349-351.
34. Lichtigfeld, F. J. & Gillman, M. A. (1984). The therapeutic use of opioid substances in psychiatry, with special reference to analgesic concentrations of nitrous oxide. In J. B. Carlile (ed.). Update of psychiatric management, pp. 76-79, (The Society of Psychiatrists of S.A Durban).
35. Lichtigfeld, F. J. & Gillman, M. A. (1989a). "The effect of placebo in the alcohol withdrawal state," Alcohol and Alcoholism, 24, 109-112.
36. Lichtigfeld, F. J. & Gillman, M A. (1989b). "Analgesic nitrous oxide for alcohol withdrawal is better than placebo," International Journal of Neuroscience, 49, 71-74.
37. Lichtigfeld, F J. & Gillman, M. A. (1994). "Psychotropic analgesic nitrous oxide and neurotransmitter mechanisms involved in the alcohol withdrawal state," International Journal of Neuroscience, 76, 17-33.
38. Lichtigfeld, F. J. & Gillman, M. A. (1996). "Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide (PAN) in alcohol and drug withdrawal." Clinical Neuropharmacology, 19, 246-251.
39. 2O, pp. 185-202, (Elsevier, New York)
40. Melzack, R & Wall, P. D. (1991). The challenge of pain, p. 210 & p. 278, (Penguin, London).
41. Ojutkangas R. (1991). "Analgesic nitrous oxide: rapid, safe therapy for addictive withdrawal," Postgraduate Medical Journal, 67, 1027-1028.
42. Ojutkangas, R. & Gillman, M. A. (1994). "Psychotropic analgesic nitrous oxide for treating alcohol withdrawal in an outpatient setting," International Journal of Neuroscience, 76, 35-39.
43. Quock, R. M., Emmanouil, D. E., Vaughn, L. K. & Pruhs, R J. (1992). "Benzodiazepine receptor mediation of behavioural effects of nitrous oxide in mice," Psychopharmacology, 107, 310-314.
44. Ross, H. E. (1993). "Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics," Addiction, 88, 209-218.
45. Rowland, A. S., Baird, D. D., Weinberg, C. R., Shore, D. L., Shy, C. M. & Wilcox, A. J (1992). "Reduced fertility among women employed as dental assistants exposed to high levels of nitrous oxide." New England Journal of Medicine, 327, 993-997.
46. Sawynok, J., Pinsky, C. & LaBella, F. S. (1979). "Minireview: on the specificity of naloxone as an opiate antagonist," Life Science, 25, 1621-1632.
47. 2O, pp. 282-304, (Elsevier, New York).
48. Spanagel, R., Herz, A. & Shippenberg, T. S. (1992). "Opposing tonically active endogenous opioid systems modulate mesolimbic dopaminergic pathway," Proceedings of the National Acadademy of Science USA, 89, 2046-2050
49. Van Heerden, B. B., Price, J. C., Jeffrey, P. J., Feldman M., Cromwell, T., Dannals, R. F., Wilson, A A., Ravert, H. T. & Frost, J. J. (1993). "The effect of nitrous oxide on the endogenous opiate system," South African Medical Journal, 83, 55.
50. Wu, K. M., Martin, W. R., Kammerling, S. G. & Wettstein, J. G (1983). "Possible medullary kappa hyperalgesic mechanism I. A new potential role for endogenous opioid peptides in pain perception," Life Science, 33, 1831-1838.
51. Zacny, J. P., Lichtor, J. L., Coalson, D. W., Apfelbaum, J. L., Flemming, D. & Foster, V. (1994). "Time course of effects of brief inhalations of nitrous oxide in normal volunteers," Addiction, 89, 831-839.